Recordati - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRecordati
Recordati logo

Recordati

0 followers

REC.MI

Performance

About Recordati

Recordati is a global pharmaceutical company headquartered in Milan, Italy, developing and commercialising medicines to treat common diseases as well as rare diseases across roughly 150 countries. With a workforce of over 4,450 employees, the company emphasizes life-enhancing and life-changing medicines and is publicly listed on the Italian stock exchange. The Group also operates in chemicals and industrial operations as part of its integrated business activities, and maintains a strong focus on sustainability and governance. Their operations span research, development, manufacturing, and commercialisation through a diversified portfolio and international presence.

Recent News

Recent Deals

Key Team Members

Robert Koremans

Chief Executive Officer

Mike McClellan

Chief Financial Officer

Alberto Martinez

Executive Vice President Specialty & Primary Care Business Unit

Scott Pescatore

Executive Vice President Rare Diseases Business Unit

Bibianne Bon

Group Chief Legal Officer

Key Facts

HQ Location

Milan, Italy

Founded

1926

Employees

1K-5K

Status

Public

Website

https://recordati.com